Pharmacy Joe

JUNE 17, 2023

Authors recently published in New England Journal of Medicine an open label multi center trial looking at early vs later anticoagulation in patients with afib who had an ischemic stroke. To access my free download area with 20 different resources to help you in your practice, go to pharmacyjoe.com/free.

Inpatient 59

Inpatient Labelling 59

Pharmacy Joe

MAY 28, 2023

If using this off-label strategy, give preference to the preservative-free version of IV tranexamic acid due to the potential adverse effects of nebulized preservatives. A reduced hemoptysis recurrence rate was noted at the 1-year follow-up (P =.009 009 in the tranexamic acid group). appeared first on Pharmacy Joe.

Inpatient 52

Inpatient Labelling Hospitals 52

Pharmacy Joe

MAY 28, 2023

If using this off-label strategy, give preference to the preservative-free version of IV tranexamic acid due to the potential adverse effects of nebulized preservatives. A reduced hemoptysis recurrence rate was noted at the 1-year follow-up (P =.009 009 in the tranexamic acid group). appeared first on Pharmacy Joe.

Inpatient 52

Inpatient Labelling Hospitals 52

Pharmacy Joe

JUNE 7, 2023

Subscribe on iTunes , Android , or Stitcher Whether torsemide improves patient Heart Failure (HF) symptoms and quality of life better than furosemide is a matter of debate among clinicians, and a group of authors recently published an open-label, multi-center, randomized trial in the journal Circulation in an effort to resolve this question.

Hospitals 59

Hospitals Inpatient Labelling 59

Pharmacy Joe

DECEMBER 7, 2022

This was an open label randomized trial of 110 patients who were evenly split between IV and nebulized tranexamic acid groups. If you like this post, check out my book – A Pharmacist’s Guide to Inpatient Medical Emergencies: How to respond to code blue, rapid response calls, and other medical emergencies. <–

Inpatient 52

Inpatient Labelling Hospitals 52

Pharmacy Joe

JUNE 17, 2023

Authors recently published in New England Journal of Medicine an open label multi center trial looking at early vs later anticoagulation in patients with afib who had an ischemic stroke. To access my free download area with 20 different resources to help you in your practice, go to pharmacyjoe.com/free.

Inpatient 52

Inpatient Labelling 52

Pharmacy Joe

SEPTEMBER 3, 2023

If you like this post, check out my book – A Pharmacist’s Guide to Inpatient Medical Emergencies: How to respond to code blue, rapid response calls, and other medical emergencies. <– To access my free download area with 20 different resources to help you in your practice, go to pharmacyjoe.com/free.

Labelling 52

Labelling Hospitals Inpatient 52

Pharmacy Joe

SEPTEMBER 3, 2023

If you like this post, check out my book – A Pharmacist’s Guide to Inpatient Medical Emergencies: How to respond to code blue, rapid response calls, and other medical emergencies. <– To access my free download area with 20 different resources to help you in your practice, go to pharmacyjoe.com/free.

Labelling 52

Labelling Hospitals Inpatient 52

Pharmacy Joe

MARCH 7, 2024

Back in episode 473 , I talked about the evidence behind the discrepancy between the labeled dose and the analgesic ceiling dose of IV ketorolac. If you like this post, check out my book – A Pharmacist’s Guide to Inpatient Medical Emergencies: How to respond to code blue, rapid response calls, and other medical emergencies. <–

Inpatient 52

Inpatient Dosage Labelling 52

Pharmacy Joe

NOVEMBER 26, 2023

Provide infusions to the nurse in the most ready-to-use form possible including obtaining the smart pump, IV tubing, spiking the bag and priming the tubing, and labeling the lines. Establish a plan for ongoing sedation with the provider. To get immediate access, go to pharmacyjoe.com/academy.

Hospitals 52

Hospitals Inpatient Labelling 52

Pharmacy Joe

DECEMBER 6, 2023

This was a multi-center trial that randomized over 800 hemodynamically unstable potential heart donors within 24 hours after declaration of death according to neurologic criteria to either an open-label infusion of intravenous levothyroxine at 30 mcg/hr or saline placebo.

Inpatient 52

Inpatient Labelling 52

Pharmacy Joe

DECEMBER 6, 2023

This was a multi-center trial that randomized over 800 hemodynamically unstable potential heart donors within 24 hours after declaration of death according to neurologic criteria to either an open-label infusion of intravenous levothyroxine at 30 mcg/hr or saline placebo.

Inpatient 52

Inpatient Labelling 52

Pharmacy Joe

NOVEMBER 26, 2023

Provide infusions to the nurse in the most ready-to-use form possible including obtaining the smart pump, IV tubing, spiking the bag and priming the tubing, and labeling the lines. Establish a plan for ongoing sedation with the provider. To get immediate access, go to pharmacyjoe.com/academy.

Hospitals 52

Hospitals Inpatient Labelling 52

Pharmacy Joe

OCTOBER 22, 2023

The ACORN randomized trial sought to compare rates of AKI and neurotoxicity in patients hospitalized with acute infection who were randomized 1:1 in an open-label fashion to receive either piperacillin-tazobactam or cefepime for gram-negative coverage. However, other studies have examined a link between increased neurotoxicity with cefepime.

Hospitals 52

Hospitals Labelling Inpatient 52

Pharmacy Joe

OCTOBER 22, 2023

The ACORN randomized trial sought to compare rates of AKI and neurotoxicity in patients hospitalized with acute infection who were randomized 1:1 in an open-label fashion to receive either piperacillin-tazobactam or cefepime for gram-negative coverage. However, other studies have examined a link between increased neurotoxicity with cefepime.

Hospitals 52

Hospitals Labelling Inpatient 52

Pharmacy Joe

AUGUST 5, 2020

If using this off-label strategy, give preference to the preservative-free version of IV tranexamic acid due to the potential adverse effects of nebulized preservatives. A reduced hemoptysis recurrence rate was noted at the 1-year follow-up (P =.009 009 in the tranexamic acid group). appeared first on Pharmacy Joe.

Inpatient 40

Inpatient Labelling Hospitals 40

Pharmacy Joe

NOVEMBER 29, 2020

To improve the data available in this patient population, investigators in Brazil completed a multicenter, randomized, open-label, noninferiority trial with 1000 patients comparing rivaroxaban with warfarin for patients with atrial fibrillation and a bioprosthetic mitral valve.

Inpatient 40

Inpatient Labelling Hospitals 40

Pharmacy Joe

NOVEMBER 10, 2021

The RECOVERY Trial, which is a randomized, controlled, open-label trial, underway at 177 hospitals recently published results of using colchicine in patients admitted to hospital with COVID-19. Patients received either placebo or colchicine 1 mg oral load followed by 0.5

Hospitals 40

Hospitals Inpatient Dosage Labelling 40

Pharmacy Joe

AUGUST 21, 2022

Recently published in Lancet was a non-inferiority, open-label, multicentre, randomized trial that sought to clarify the safety of early antibiotic discontinuation in hematology patients with fever of unknown origin during chemotherapy-induced neutropenia.

Chemotherapy 52

Chemotherapy Inpatient Labelling 52

Pharmacy Joe

SEPTEMBER 7, 2022

Milrinone labeling suggests a renal dose adjustment for patients with creatinine clearance between 10 and 50 mL/min but has no recommendations or data available for patients with ESRD or who are receiving CRRT.

Hospitals 52

Hospitals Inpatient Labelling 52

Pharmacy Joe

DECEMBER 7, 2022

This was an open label randomized trial of 110 patients who were evenly split between IV and nebulized tranexamic acid groups. If you like this post, check out my book – A Pharmacist’s Guide to Inpatient Medical Emergencies: How to respond to code blue, rapid response calls, and other medical emergencies. <–

Inpatient 40

Inpatient Labelling Hospitals 40

Pharmacy Joe

NOVEMBER 25, 2020

If you like this post, check out my book – A Pharmacist’s Guide to Inpatient Medical Emergencies: How to respond to code blue, rapid response calls, and other medical emergencies. <– To access my free download area with 20 different resources to help you in your practice, go to pharmacyjoe.com/free.

Labelling 40

Labelling Hospitals Inpatient 40

Pharmacy Joe

AUGUST 16, 2023

By predicting this need in advance, calculating doses, preparing and labeling syringes, the pharmacist can also enhance medication safety and free up the rest of the care team to remain hands-on with the patient ensuring adequate pre-oxygenation, IV access, and supportive care.

Hospitals 52

Hospitals Inpatient Labelling 52

Pharmacy Joe

MARCH 17, 2021

Provide infusions to the nurse in the most ready-to-use form possible including obtaining the smart pump, IV tubing, spiking the bag and priming the tubing, and labeling the lines. Establish a plan for ongoing sedation with the provider. To get immediate access, go to pharmacyjoe.com/academy.

Hospitals 40

Hospitals Inpatient Labelling 40

Pharmacy Joe

NOVEMBER 12, 2023

Secondary outcome measures were numerically favorable for haloperidol including the need for open-label haloperidol or other antipsychotics, and self-extubation or invasive device removal. However none of these secondary outcomes reached statistical significance.

Hospitals 52

Hospitals Inpatient Labelling 52

Pharmacy Joe

NOVEMBER 12, 2023

Secondary outcome measures were numerically favorable for haloperidol including the need for open-label haloperidol or other antipsychotics, and self-extubation or invasive device removal. However none of these secondary outcomes reached statistical significance.

Hospitals 52

Hospitals Inpatient Labelling 52

Pharmacy Joe

SEPTEMBER 20, 2021

Back in episode 473 , I talked about the evidence behind the discrepancy between the labeled dose and the analgesic ceiling dose of IV ketorolac. If you like this post, check out my book – A Pharmacist’s Guide to Inpatient Medical Emergencies: How to respond to code blue, rapid response calls, and other medical emergencies. <–

Inpatient 40

Inpatient Dosage Labelling 40

Pharmacy Joe

OCTOBER 3, 2021

A group of authors recently published in NEJM the results of a randomized, multicenter, open-label, parallel-group trial in the UK examining this issue. If you like this post, check out my book – A Pharmacist’s Guide to Inpatient Medical Emergencies: How to respond to code blue, rapid response calls, and other medical emergencies. <–

Hospitals 40

Hospitals Inpatient Labelling 40

Pharmacy Joe

MAY 25, 2022

A group of authors from Sorbonne University in Paris, France conducted a randomized open label multicenter trial to examine whether an 8 day course of therapy for Pseudomonas VAP (PA-VAP) could be non-inferior to a 15 day course. 25 of 98 patients in the 15-day group and 31 of 88 patients in the 8-day group reached the composite endpoint.

Inpatient 40

Inpatient Labelling Hospitals 40

Pharmacy Joe

FEBRUARY 15, 2023

Such a recommendation, even though it is labeled as weak and based on very low-quality evidence is likely to make its way into hospital protocol in the form of automatically discontinuing a C diff test for a patient with recent laxative use. Members of my Hospital Pharmacy Academy have access to practical trainings on C.

Inpatient 40

Inpatient Hospitals Labelling 40

Pharmacy Joe

APRIL 20, 2022

This was a multicenter, open-label, noninferiority randomized clinical trial of 206 ICU patients with VAP. If you like this post, check out my book – A Pharmacist’s Guide to Inpatient Medical Emergencies: How to respond to code blue, rapid response calls, and other medical emergencies. <–

Inpatient 40

Inpatient Labelling 40

Pharmacy Joe

DECEMBER 22, 2021

The study was a prospective, randomized, open-label, parallel assignment, single-center clinical trial of 801 patients. If you like this post, check out my book – A Pharmacist’s Guide to Inpatient Medical Emergencies: How to respond to code blue, rapid response calls, and other medical emergencies. <–

Inpatient 40

Inpatient Labelling 40

Pharmacy Joe

AUGUST 21, 2022

Recently published in Lancet was a non-inferiority, open-label, multicentre, randomized trial that sought to clarify the safety of early antibiotic discontinuation in hematology patients with fever of unknown origin during chemotherapy-induced neutropenia.

Chemotherapy 40

Chemotherapy Inpatient Labelling 40

Pharmacy Joe

SEPTEMBER 7, 2022

Milrinone labeling suggests a renal dose adjustment for patients with creatinine clearance between 10 and 50 mL/min but has no recommendations or data available for patients with ESRD or who are receiving CRRT.

Hospitals 40

Hospitals Inpatient Labelling 40

Pharmacy Joe

SEPTEMBER 30, 2020

By predicting this need in advance, calculating doses, preparing and labeling syringes, the pharmacist can also enhance medication safety and free up the rest of the care team to remain hands-on with the patient ensuring adequate pre-oxygenation, IV access, and supportive care.

Hospitals 40

Hospitals Inpatient Labelling 40

Pharmacy Joe

DECEMBER 27, 2020

The study was a single-center, randomized, open-label pilot study. If you like this post, check out my book – A Pharmacist’s Guide to Inpatient Medical Emergencies: How to respond to code blue, rapid response calls, and other medical emergencies. <– One for Sodium Zirconium Cyclosilicate and one for Patiromer.

Inpatient 40

Inpatient Labelling 40

Pharmacy Joe

SEPTEMBER 6, 2021

If you like this post, check out my book – A Pharmacist’s Guide to Inpatient Medical Emergencies: How to respond to code blue, rapid response calls, and other medical emergencies. <–

Hospitals 52

Hospitals Documentation Medical Records Inpatient 52